The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women.

Pfaus, James G et al.·CNS spectrums·2022·
RPEP-064312022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Bremelanotide activates melanocortin receptors, particularly MC4R, to potentially increase dopamine release.

Key Numbers

How They Did This

This is a review study summarizing existing research on bremelanotide's mechanism of action.

Why This Research Matters

Understanding how bremelanotide works can improve treatment options for women suffering from HSDD. This could lead to better management of female sexual dysfunction.

What This Study Doesn't Tell Us

As a review, it summarizes existing studies but does not present new experimental data.

Trust & Context

Original Title:
The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women.
Published In:
CNS spectrums, 27(3), 281-289 (2022)
Database ID:
RPEP-06431

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06431·https://rethinkpeptides.com/research/RPEP-06431

APA

Pfaus, James G; Sadiq, Amama; Spana, Carl; Clayton, Anita H. (2022). The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women.. CNS spectrums, 27(3), 281-289. https://doi.org/10.1017/S109285292100002X

MLA

Pfaus, James G, et al. "The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women.." CNS spectrums, 2022. https://doi.org/10.1017/S109285292100002X

RethinkPeptides

RethinkPeptides Research Database. "The neurobiology of bremelanotide for the treatment of hypoa..." RPEP-06431. Retrieved from https://rethinkpeptides.com/research/pfaus-2022-the-neurobiology-of-bremelanotide

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.